Clinical Trial Results: Trial to Assess the Safety and Preliminary Efficacy of GEN1055 on Malignant Solid Tumors as Monotherapy and as Combination Therapy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating GEN1055 as monotherapy and in combination for malignant solid tumors has been terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Solid Tumor

Drugs mentioned

• GEN1055

Snippet

Sponsor: Genmab | Conditions: Malignant Solid Tumor | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2026-08-11